ArticleCurrent pharmaceutical design2024

Exploring the Biomarkers and Potential Mechanisms of Botulinum Toxin Type A in the Treatment of Microglial Inflammatory Activation through P2X7 Receptors based on Transcriptome Sequencing.

Kai Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.